Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 4-[[[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]amino]methyl]-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

905818-70-4

Post Buying Request

905818-70-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

905818-70-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 905818-70-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,8,1 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 905818-70:
(8*9)+(7*0)+(6*5)+(5*8)+(4*1)+(3*8)+(2*7)+(1*0)=184
184 % 10 = 4
So 905818-70-4 is a valid CAS Registry Number.

905818-70-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4-{[(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)amino]methyl}benzoate

1.2 Other means of identification

Product number -
Other names 4-{[2-(tert-Butyl-dimethyl-silanyloxy)-ethylamino]-methyl}-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:905818-70-4 SDS

905818-70-4Relevant academic research and scientific papers

SELECTIVE HDAC6 INHIBITORS

-

, (2015/07/15)

The present invention provides hydroxamic acids of the formula described herein, that have activity toward inhibiting histone deacetylases, and in particular HDAC6. Also contemplated are pharmaceutical compositions and methods of use of an effective amount of the hydroxamic acid compounds provided, for treating a disease in a subject. In certain embodiments, the subject is afflicted with cancer, neurodegenerative disease, or HIV infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 905818-70-4